PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+20.34%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$891M
AUM Growth
+$891M
(+10%)
Cap. Flow
-$1.62M
Cap. Flow
% of AUM
-0.18%
Top 10 Holdings %
Top 10 Hldgs %
48.29%
Holding
160
New
50
Increased
18
Reduced
30
Closed
32
Top Buys
| 1 |
Iovance Biotherapeutics
IOVA
|
$28.3M |
| 2 |
Heron Therapeutics
HRTX
|
$24.5M |
| 3 |
PTC Therapeutics
PTCT
|
$17.6M |
| 4 |
Acadia Pharmaceuticals
ACAD
|
$16.2M |
| 5 |
ARAV
Aravive, Inc. Common Stock
ARAV
|
$15.1M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$42.3M |
| 2 |
AEGR
Aegerion Pharmaceuticals, Inc.
AEGR
|
$31.8M |
| 3 |
MannKind Corp
MNKD
|
$19.8M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$16.3M |
| 5 |
Sarepta Therapeutics
SRPT
|
$14.6M |
Sector Composition
| 1 | Healthcare | 88.32% |
| 2 | Technology | 0.04% |
| 3 | Industrials | 0.02% |
| 4 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMRX
51
DELISTED
Chimerix, Inc.
CMRX
| $3.2M | 0.34% |
140,000
-10,000
| -7% | -$229K |
|
|
FPRX
52
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $2.95M | 0.31% |
150,000
+17,500
| +13% | +$344K |
|
|
VXRT
53
DELISTED
Vaxart
VXRT
| $2.54M | 0.27% |
+415,000
| New | +$2.54M |
|
54
Verastem
VSTM
$585M
| $2.39M | 0.25% |
220,000
| – | – |
|
55
Tandem Diabetes Care
TNDM
$834M
| $2.34M | 0.25% |
105,900
-19,700
| -16% | -$435K |
|
|
MGCD
56
DELISTED
MGC Diagnostics Corporation
MGCD
| $2.31M | 0.24% |
206,957
+27,338
| +15% | +$305K |
|
|
ATHX
57
DELISTED
Athersys, Inc. Common Stock
ATHX
| $2.27M | 0.24% |
701,582
-999,305
| -59% | -$3.24M |
|
|
GNVC
58
DELISTED
GenVec, Inc.
GNVC
| $2.17M | 0.23% |
+820,000
| New | +$2.17M |
|
|
MDVN
59
DELISTED
MEDIVATION, INC.
MDVN
| $2.05M | 0.22% |
+31,900
| New | +$2.05M |
|
60
Amicus Therapeutics
FOLD
$2.42B
| $2M | 0.21% |
+966,300
| New | +$2M |
|
61
AtriCure
ATRC
$1.73B
| $1.88M | 0.2% |
+100,000
| New | +$1.88M |
|
|
UPI
62
DELISTED
UROPLASTY INC-NEW
UPI
| $1.88M | 0.2% |
517,791
+203,802
| +65% | +$740K |
|
|
OXGN
63
DELISTED
OXIGENE INC COM
OXGN
| $1.87M | 0.2% |
+500,000
| New | +$1.87M |
|
|
QCOR
64
DELISTED
QUESTCOR PHARMA INC
QCOR
| $1.86M | 0.2% |
+28,600
| New | +$1.86M |
|
65
Compugen
CGEN
$133M
| $1.79M | 0.19% |
+170,000
| New | +$1.79M |
|
66
Neurogene
NGNE
$284M
| $1.66M | 0.17% |
+130,000
| New | +$1.66M |
|
|
CASC
67
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $1.62M | 0.17% |
543,000
+43,000
| +9% | +$129K |
|
|
BDSI
68
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $1.6M | 0.17% |
+190,000
| New | +$1.6M |
|
|
ICAD
69
DELISTED
iCAD Inc
ICAD
| $1.6M | 0.17% |
+175,000
| New | +$1.6M |
|
|
ANTH
70
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $1.6M | 0.17% |
478,456
+47,000
| +11% | +$157K |
|
|
ELOS
71
DELISTED
Syneron Medical Ltd
ELOS
| $1.59M | 0.17% |
+127,500
| New | +$1.59M |
|
|
ENZ
72
DELISTED
Enzo Biochem, Inc.
ENZ
| $1.58M | 0.17% |
+380,000
| New | +$1.58M |
|
|
RCPT
73
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $1.47M | 0.15% |
+35,000
| New | +$1.47M |
|
74
ANI Pharmaceuticals
ANIP
$2.06B
| $1.41M | 0.15% |
+45,000
| New | +$1.41M |
|
75
DURECT Corp
DRRX
$60.2M
| $1.21M | 0.13% |
+907,064
| New | +$1.21M |
|